<DOC>
	<DOC>NCT02024035</DOC>
	<brief_summary>The purpose of this study is to do health economic evaluation of tomotherapy and dynamic arctherapy (2 techniques exist: RapidArc and Vmat). This study evaluate also local disease control after 18 months in patients with an ENT epidermoid carcinoma and treated by tomotherapy orarctherapy . The number of patients required in this study is: 300: - Number of patients treated with tomotherapy: 120 - Number of patients treated with dynamic arctherapy RapidArc: 120 - Number of patients treated with dynamic arctherapy Vmat: 60 This is a prospective; multicentric and non randomized study.</brief_summary>
	<brief_title>Protocole Advanced RadioTherapy ORL</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>PS &lt;= 2 Age &gt;= 18 years Histologically proven carcinoma Cavum Epidermoïd or undifferentiated carcinoma; or oropharynx epidermoïd carcinoma; or oral cavity epidermoïd carcinoma Stade T1 to T4 M0 Patient with no surgery ( except laser partial surgery and ganglionic cleaning out) Bilateral ganlionic cervical area irradiation Covered by a medical insurance. Prior history of other malignancies in the last 5 years(except non evolutive ENT cancer or squamous cell carcinoma ) Reirradiation indication Unilateral cervical area irradiation Postoperative radiotherapy Patient treated by amifostine Impossible followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Tomotherapy</keyword>
	<keyword>Head and neck squamous celle carcinoma</keyword>
	<keyword>Health economic evaluation</keyword>
</DOC>